Application | Comment | Organism |
---|---|---|
medicine | Plk1 is a target for the development of anticancer therapeutics | Homo sapiens |
medicine | Plk1 is a target for the development of anticancer therapeutics | Danio rerio |
Cloned (Comment) | Organism |
---|---|
full-length hPlk1 cDNA is inserted into a pCMV plasmid and subcloned into pGEX6P-1, the hPlk1 kinase domain sequences for crystallography and activity constructs encompassing amino acids 1-346 | Homo sapiens |
full-length zPlk1 cDNA is inserted into the pME18S-FL3 plasmid and subcloned into pGEX6P-1, the zPlk1 kinase domain sequences for crystallography and activity constructs encompassing amino acids 1-312 or 17-312 | Danio rerio |
Crystallization (Comment) | Organism |
---|---|
the structures of wild-type zPlk KD, mutant T196D, wild-type zPlk KD in complex with ADP and the mutant T196D in complex with wortmannin are determined at resolutions of 2.8, 2.4, 2.6 and 2.6 A, respectively | Danio rerio |
Protein Variants | Comment | Organism |
---|---|---|
T196D | variant containing an activating substitution | Danio rerio |
T210D | variant containing an activating substitution | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Wortmannin | - |
Danio rerio | |
Wortmannin | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0055 | - |
ATP | apparent Km, hPlk1 1-346 T210D | Homo sapiens | |
0.0064 | - |
ATP | apparent Km, zPlk1 1-312 T196D | Danio rerio | |
0.0076 | - |
ATP | apparent Km, zPlk1 1-312 wild type | Danio rerio |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
35920 | - |
expected molecular weight of the protein with the N-terminal Gly-Pro-Leu-Gly-Ser linker residues that separate the GST protein from Plk1 KD | Danio rerio |
35930 | - |
expected molecular weight of the protein with the additional T196D substitution | Danio rerio |
39050 | - |
expected molecular weight of the protein with the N-terminal Gly-Pro-Leu-Gly-Ser linker residues that separate the GST protein from Plk1 KD | Homo sapiens |
39060 | - |
expected molecular weight of the protein with the additional T210D substitution | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + protein | Homo sapiens | - |
ADP + phosphoprotein | - |
? | |
ATP + protein | Danio rerio | - |
ADP + phosphoprotein | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Danio rerio | Q6DRK7 | - |
- |
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
using a glutathione-Sepharose and a Q-Sepharose column | Homo sapiens |
using a glutathione-Sepharose and a Q-Sepharose column | Danio rerio |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + casein | substrate in biochemical activity assay | Homo sapiens | ADP + phosphocasein | - |
? | |
ATP + casein | substrate in biochemical activity assay | Danio rerio | ADP + phosphocasein | - |
? | |
ATP + protein | - |
Homo sapiens | ADP + phosphoprotein | - |
? | |
ATP + protein | - |
Danio rerio | ADP + phosphoprotein | - |
? |
Synonyms | Comment | Organism |
---|---|---|
hPlk1 | - |
Homo sapiens |
Plk1 | - |
Homo sapiens |
Plk1 | - |
Danio rerio |
Polo-like kinase 1 | - |
Homo sapiens |
Polo-like kinase 1 | - |
Danio rerio |
zPlk1 | - |
Danio rerio |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00229 | - |
ATP | zPlk1 1-312 wild type | Danio rerio | |
0.01311 | - |
ATP | zPlk1 1-312 T196D | Danio rerio | |
0.01386 | - |
ATP | hPlk1 1-346 T210D | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.2 | - |
activity assay | Homo sapiens |
7.2 | - |
activity assay | Danio rerio |